Insider · CIK 0001349083

Jeffrey B Davis

Reports to the SEC for 3 companies · DALLAS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001349083

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-12-14	ABEOABEONA THERAPEUTICS INC. · Stock option (right to buy)A Award	COO	AAward	+20K sh	—	—	20,000
2017-12-14	ABEOABEONA THERAPEUTICS INC. · Stock option (right to buy)A Award	COO	AAward	+60K sh	—	—	60,000
2016-12-13	ABEOABEONA THERAPEUTICS INC. · Stock option (right to buy)A Award	COO	AAward	+37.5K sh	—	—	37,500
2016-12-13	ABEOABEONA THERAPEUTICS INC. · Stock option (right to buy)A Award	COO	AAward	+113K sh	—	—	150,000
2016-02-11	ABEOABEONA THERAPEUTICS INC. · Stock option (right to buy)A Award	COO	AAward	+37.5K sh	—	—	37,500
2016-02-11	ABEOABEONA THERAPEUTICS INC. · Stock option (right to buy)A Award	COO	AAward	+113K sh	—	—	150,000
2015-05-11	ABEOABEONA THERAPEUTICS INC. · Stock option (right to buy)A Award	COO	AAward	+100K sh	—	—	100,000
2015-05-11	ABEOABEONA THERAPEUTICS INC.A Award	COO	AAward	+300K sh	$7.34	+$2.2M	300,000
2015-05-11	ABEOABEONA THERAPEUTICS INC. · Stock option (right to buy)A Award	COO	AAward	+100K sh	$7.34	+$734K	140,500
2015-05-11	ABEOABEONA THERAPEUTICS INC.A Award	COO	AAward	+300K sh	—	—	300,000
2014-12-24	ABEOABEONA THERAPEUTICS INC.J Other	COO	JOther	+301K sh	$4.00	+$1.2M	963,511
2014-12-24	ABEOABEONA THERAPEUTICS INC. · Common Stock Purchase WarrantsP Purchase	COO	PPurchase	+62.5K sh	$0.01	+$625	62,500
2014-12-24	ABEOABEONA THERAPEUTICS INC. · Series A Cumulative Convertible Preferred StockC Conversion	COO	CConversion	−237.921 sh	$4.00	−$951.682	0
2014-12-24	ABEOABEONA THERAPEUTICS INC.P Purchase	COO	PPurchase	+62.5K sh	$4.00	+$250K	67,858
2014-12-24	ABEOABEONA THERAPEUTICS INC.J Other	COO	JOther	+595K sh	$4.00	+$2.38M	662,659
2014-09-25	Altrazeal Life Sciences Inc.Stock Option (Right to Buy)A Award	Director	AAward	+100K sh	$1.15	+$115K	100,000
2014-03-07	ABEOABEONA THERAPEUTICS INC. · Stock option (right to buy)A Award	COO	AAward	+1.5M sh	$0.37	+$555K	2,025,000
2014-03-07	ABEOABEONA THERAPEUTICS INC. · Stock option (right to buy)A Award	COO	AAward	+500K sh	$0.37	+$185K	525,000
2013-03-20	Altrazeal Life Sciences Inc.Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2010-04-26	Altrazeal Life Sciences Inc.Stock Option (Right to Buy)A Award	Director	AAward	+500K sh	$0.17	+$85K	750,000
2009-02-04	ABEOABEONA THERAPEUTICS INC.J Other	COO	JOther	+74.7K sh	$0.96	+$71.6K	173,250
2009-02-04	ABEOABEONA THERAPEUTICS INC.J Other	COO	JOther	+24.9K sh	$2.75	+$68.5K	173,250
2009-02-04	ABEOABEONA THERAPEUTICS INC.J Other	COO	JOther	+5,950 sh	$3.00	+$17.9K	173,250
2008-06-19	Altrazeal Life Sciences Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	$0.92	+$23K	250,000
2008-04-25	MACROCHEM CORPJ Other	Director	JOther	+2.14M sh	—	—	2,973,693
2008-02-04	ABEOABEONA THERAPEUTICS INC. · Common Stock Purchase WarrantP Purchase	COO	PPurchase	+41.7K sh	—	—	41,667
2008-02-04	ABEOABEONA THERAPEUTICS INC. · Series A Cumulative Convertible Preferred StockP Purchase	COO	PPurchase	+25 sh	$10000.00	+$250K	237.921
2008-02-04	ABEOABEONA THERAPEUTICS INC. · Placement Agent WarrantsP Purchase	COO	PPurchase	+5,750 sh	—	—	5,750
2007-05-08	Altrazeal Life Sciences Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	$4.95	+$124K	175,000

Recent filings

Accepted (ET)
Dec 184
Jeffrey B Davis0000318306-17-000002
SEC(opens sec.gov)
Dec 154
ABEONA THERAPEUTICS INC.0000318306-16-000051
SEC(opens sec.gov)
Feb 164
ABEONA THERAPEUTICS INC.0000318306-16-000045
SEC(opens sec.gov)
Jun 194/A
ABEONA THERAPEUTICS INC.0000318306-15-000033
SEC(opens sec.gov)
May 134
PLASMATECH BIOPHARMACEUTICALS INC0000318306-15-000022
SEC(opens sec.gov)
Dec 294
PLASMATECH BIOPHARMACEUTICALS INC0000318306-14-000049
SEC(opens sec.gov)
Sep 294
ULURU Inc.0001372353-14-000002
SEC(opens sec.gov)
Mar 114
ACCESS PHARMACEUTICALS INC0000318306-14-000002
SEC(opens sec.gov)
Mar 224
ULURU INC.0001372353-13-000005
SEC(opens sec.gov)
Apr 284
ULURU INC.0001168220-10-000030
SEC(opens sec.gov)

Companies

Address

C/O ACCESS PHARMACEUTICALS INC 2600 STEMMONS FREEWAY SUITE 176

DALLAS, TX, 75207